{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-007658","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2025-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.321614+00:00","generated_at":"2026-05-25T04:00:44.852920+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Senti Biosciences stockholders approve share issuance and amended equity plan","bullets":["Approved issuance of common stock upon conversion of Series A preferred and exercise of warrants (2,442,111 for, 125,063 against).","Approved Amended and Restated 2022 Equity Incentive Plan (2,196,615 for, 371,748 against).","Approved adjournment to solicit additional proxies if needed (2,258,129 for).","Equity plan adds 4,816,434 shares plus annual 5% evergreen increase through 2034."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-007658","json":"https://secwatch.observer/filing/0001140361-25-007658.json","markdown":"https://secwatch.observer/filing/0001140361-25-007658.md","text":"https://secwatch.observer/filing/0001140361-25-007658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/0001140361-25-007658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/ef20045105_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T04:00:44.852920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}